Recent mechanistic studies which comprehensively link hyperglycemia and hyperlipidemia with aberrant RhoA/ROCK activity have shown that the increased production of proinflammatory cytokines and oxidative stress can disturb miRNA expression which subsequently change RhoA/ROCK expression and activity as well (77, 78). The gene discussed is RHOA; the disease is hyperlipidemia.